March Biosciences

📍 Houston, United States👥 25 employees💰 Last funded Jan 2025
Biotechnology🌐 march.bio
Website LinkedIn
March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient care in the most challenging hematological malignancies. March Bios lead asset is at the end of Phase I trials for T-cell malignancies, diseases with a dismal prognosis that is currently unaddressed by CAR-T and targeted therapy technologies. The companys pipeline is designed to expand on these early successes to more broadly impact other high-challenge cancers.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Frequently asked questions
Who invested in March Biosciences?
March Biosciences has 3 investors on record on gritt.io.
When did March Biosciences last raise funding?
The most recent investment in March Biosciences recorded on gritt.io was in January 2025.
What industry is March Biosciences in?
March Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is March Biosciences based?
March Biosciences is headquartered in Houston, United States.